Fibrous Dysplasia

Pediatric Bone

Volumn , Issue , 2012, Pages 589-624

  Bianco, Paolo ^a   Wientroub, Shlomo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882900197     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382040-2.10022-X     Document Type: Chapter

References (315)

1. Albright F., Butler A.M., Hampton A.O., Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N Engl J Med 1937, 216:727-746.
2. Albright F., Scoville B., Sulkowitch H.W. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and a gonadal dysfunction: further observations including the report of two more cases. Endocrinology 1938, 22:411-421.
3. McCune D.J., Bruch H. Progress in pediatrics: Osteodystrophia fibrosa. Am J Dis Child 1937, 54:806-848.
4. von Recklinghausen F. Die fibrose order deformierende Ostitis, die Osteomalazie und die osteoplastische Karzinose in ihren gegenseitigen Beziehungen. Festschrift fur Rudolf Virchow 1891, Reiner, Berlin.
5. Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg 1938, 36:874-879.
6. Lichtenstein L., Jaffe H.L. Fibrous dysplasia of bone: a condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism and still other extraskeletal abnormalities. Arch Pathol 1942, 33:777-797.
7. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991, 325:1688-1695.
8. Schwindinger W.F., Francomano C.A., Levine M.A. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 1992, 89:5152-5156.
9. Yamamoto T., Ozono K., Kasayama S., et al. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 1996, 98:30-35.
10. Riminucci M., Fisher L.W., Shenker A., Spiegel A.M., Bianco P., Gehron Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997, 151:1587-1600.
11. Shenker A., Chanson P., Weinstein L.S., et al. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 1995, 4:1675-1676.
12. Marie P.J., de Pollak C., Chanson P., Lomri A. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 1997, 150:1059-1069.
13. Bianco P., Kuznetsov S., Riminucci M., Fisher L.W., Spiegel A.M., Gehron Robey P. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs-alpha mutated skeletal progenitor cells. J Clin Invest 1998, 101:1737-1744.
14. Cole D.E.C., Fraser F.C., Glorieux F.H., et al. Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia. Am J Med Genet 1983, 14:725-735.
15. Ascenzi A. Physiological relationship and pathological interferences between bone tissue and marrow. The Biochemistry and Physiology of Bone 1976, 403-445. Academic Press, New York. 2nd ed. G.H. Bourne (Ed.).
16. MacMahon H.E. Albright s syndrome - thirty years later. Pathol Annu 1971, 6:81-146.
17. Dorfman H.D., Ishida T., Tsuneyoshi M. Exophytic variant of fibrous dysplasia (fibrous dysplasia protuberans). Hum Pathol 1994, 25:1234-1237.
18. Dorfman H.D., Czerniak B. Bone Tumors 1997, Mosby, St Louis.
19. Comite F., Shawker T.H., Pescovitz O.H., Loriaux D.L., Cutler G.B. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. N Engl J Med 1984, 311:1032-1036.
20. Foster C.M., Feuillan P., Padmanabhan V., et al. Ovarian function in girls with McCune-Albright syndrome. Pediatr Res 1986, 20:859-863.
21. Foster C.M., Levine Ross J., Shawker T., et al. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endo Metab 1984, 58:1161-1165.
22. Feuillan P.P. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1994, 5:205-209.
23. Feuillan P.P. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1997, 6:235-239.
24. Pienkowski C., Lumbroso S., Bieth E., Sultan C., Rochiccioli P., Tauber M. Recurrent ovarian cyst and mutation of the Gs alpha gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome?. Acta Paediatr 1997, 86:1019-1021.
25. Arrigo T., Pirazzoli P., De Sanctis L., et al. McCune-Albright syndrome in a boy may present with a monolateral macroorchidism as an early and isolated clinical manifestation. Horm Res 2006, 65:114-119.
26. Chakrabarti S., Marshall I. Another unusual presentation of McCune Albright syndrome with fibrous dysplasia, unilateral testicular enlargement, and testicular microlithiasis. J Pediatr Endocrinol Metab 2010, 23:513-515.
27. De Luca F., Mitchell V., Wasniewska M., et al. Regulation of spermatogenesis in McCune-Albright syndrome: lessons from a 15-year follow-up. Eur J Endocrinol 2008, 158:921-927.
28. Mamkin I., Philibert P., Anhalt H., Ten S., Sultan C. Unusual phenotypical variations in a boy with McCune-Albright syndrome. Horm Res Paediatr 2010, 73:215-222.
29. Rey R.A., Venara M., Coutant R., et al. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet 2006, 15:3538-3543.
30. Savas Erdeve S., Balta H., Balta Z., Dallar Y. Testicular microlithiasis and McCune-Albright syndrome. J Pediatr 2006, 148:422. Author reply 422-3.
31. Wasniewska M., De Luca F., Bertelloni S., et al. Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males. J Pediatr 2004, 145:670-672.
32. Akintoye S.O., Chebli C., Booher S., et al. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 2002, 87:5104-5112.
33. Barlier A., Gunz G., Zamora A.J., et al. Prognostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. J Clin Endocrinol Metab 1998, 83:1604-1610.
34. Dotsch J., Kiess W., Hanze J., et al. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. J Clin Endocrinol Metab 1996, 81:3839-3842.
35. Nakagawa H., Nagasaka A., Sugiura T., et al. Gigantism associated with McCune-Albright s syndrome. Horm Metab Res 1985, 17:522-527.
36. Pacini F., Perri G., Bagnolesi P., Cilotti A., Pinchera A. McCune-Albright syndrome with gigantism and hyperprolactinemia. J Endocrinol Invest 1987, 10:417-420.
37. Polychronakos C., Tsoukas G., Ducharme J.R., Letarte J., Collu R. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J Endocrinol Invest 1982, 5:323-326.
38. Queirolo S., Gallarotti F., Capuano E., Garre M.L., Spaziante R., Di Battista E. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome. J Pediatr Endocrinol Metab 2009, 22:177-179.
39. Chanson P., Dib A., Visot A., Derome P.J. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994, 131:229-234.
40. Daly B.D., Chow C.C., Cockram C.S. Unusual manifestations of craniofacial fibrous dysplasia: clinical, endocrinological and computed tomographic features. Postgrad Med J 1994, 70:10-16.
41. Boston B.A., Mandel S., LaFranchi S., Bliziotes M. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing s syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 1994, 79:890-893.
42. Danon M., Robboy S.J., Kim S., Scully R., Crawford J.D. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 1975, 87:917-921.
43. Kirk J.M.W., Brain C.E., Carson D.J., Hyde J.C., Grant D.B. Cushing s syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999, 134:789-792.
44. Brown R.J., Kelly M.H., Collins M.T. Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab 2010, 95:1508-1515.
45. Paris F., Philibert P., Lumbroso S., Servant N., Kalfa N., Sultan C. Isolated Cushing s syndrome: an unusual presentation of McCune-Albright syndrome in the neonatal period. Horm Res 2009, 72:315-319.
46. Gillis D., Rosler A., Hannon T.S., Koplewitz B.Z., Hirsch H.J. Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome. J Pediatr 2008, 152:882-884. 884.
47. Fragoso M.C., Domenice S., Latronico A.C., et al. Cushing s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003, 88:2147-2151.
48. Riminucci M., Collins M., Lala R., et al. An R201H activating mutation of the GNAS1 (Gs alpha) gene in a corticotroph pituitary adenoma. Mol Pathol 2002, 55:58-60.
49. Williamson E.A., Ince P.G., Harrison D., Kendall-Taylor P., Harris P.E. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 1995, 25:128-131.
50. Mastorakos G., Mitsiades N.S., Doufas A.G., Koutras D.A. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 1997, 7:433-439.
51. Collins M.T., Sarlis N.J., Merino M.J., et al. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 2003, 88:4413-4417.
52. Kaplan F.S., Fallon M.D., Boden S.D., Schmidt R., Senior M., Haddad J.G. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med 1988, 319:421-425.
53. Kim I.S., Kim E.R., Nam H.J., et al. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res 1999, 52:235-240.
54. Henschen F., Fallon H. Ostitis fibrosa mit multiplen tumores in der umgebenden muskulature. Verh Dtsch Ges Pathol 1926, 21:93-97.
55. Mazabraud A., Girard J. Un cas particulier de dysplasis fibreuse a localisations osseuses et tendineuses. Rev Rhum 1957, 34:652-659.
56. Mazabraud A., Semat P., Rose R. A propos de l association de fibromixomes des tissus mous a la dysplasie fibreuse de l os. Press Med 1967, 75:2223-2228.
57. Aoki T., Kouho H., Hisaoka M., Hashimoto H., Nakata H., Sakai A. Intramuscular myxoma with fibrous dysplasia: a report of two cases with a review of the literature. Pathol Int 1995, 45:165-171.
58. Cabral C.E., Guedes P., Fonseca T., Rezende J.F., Cruz Junior L.C., Smith J. Polyostotic fibrous dysplasia associated with intramuscular myxomas: Mazabraud s syndrome. Skeletal Radiol 1998, 27:278-282.
59. Szendroi M., Rahoty P., Antal I., Kiss J. Fibrous dysplasia associated with intramuscular myxoma (Mazabraud s syndrome): a long-term follow-up of three cases. J Cancer Res Clin Oncol 1998, 124:401-406.
60. Thomachot B., Daumen-Legre V., Pham T., Acquaviva P.C., Lafforgue P. Fibrous dysplasia with intramuscular myxoma (Mazabraud s syndrome). Report of a case and review of the literature. Rev Rhum Engl Ed 1999, 66:180-183.
61. Wirth W.A., Leavitt D., Enzinger F.M. Multiple intramuscular myxomas: another extraskeletal manifestation of fibrous dysplasia. Cancer 1971, 27:1167-1173.
62. Calisir C., Inan U., Yavas U.S., Isiksoy S., Kaya T. Mazabraud s syndrome coexisting with a uterine tumor resembling an ovarian sex cord tumor (UTROSCT): a case report. Korean J Radiol 2007, 8:438-442.
63. Endo M., Kawai A., Kobayashi E., et al. Solitary intramuscular myxoma with monostotic fibrous dysplasia as a rare variant of Mazabraud s syndrome. Skeletal Radiol 2007, 36:523-529.
64. Santos C.T., Choo C.T., Loh A.H. Orbital fibrous dysplasia with soft tissue hamartoma - a variant of Mazabraud s syndrome. Orbit 2008, 27:207-209.
65. Zoccali C., Teori G., Prencipe U., Erba F. Mazabraud s syndrome: a new case and review of the literature. Int Orthop 2009, 33:605-610.
66. Okamoto S., Hisaoka M., Ushijima M., Nakahara S., Toyoshima S., Hashimoto H. Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch 2000, 437:133-137.
67. Delaney D., Diss T.C., Presneau N., et al. GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol 2009, 22:718-724.
68. Tsai C.C., Saffitz J.E., Billadello J.J. Expression of the Gs protein alpha-subunit disrupts the normal program of differentiation in cultured murine myogenic cells. J Clin Invest 1997, 99:67-76.
69. Corsi A., De Maio F., Ippolito E., et al. Monostotic fibrous dysplasia of the proximal femur and liposclerosing myxofibrous tumor: which one is which?. J Bone Miner Res 2006, 21:1955-1958.
70. Heim-Hall J.M., Williams R.P. Liposclerosing myxofibrous tumour: a traumatized variant of fibrous dysplasia? Report of four cases and review of the literature. Histopathology 2004, 45:369-376.
71. Matsuba A., Ogose A., Tokunaga K., et al. Activating Gs alpha mutation at the Arg201 codon in liposclerosing myxofibrous tumor. Hum Pathol 2003, 34:1204-1209.
72. Silva E.S., Lumbroso S., Medina M., Gillerot Y., Sultan C., Sokal E.M. Demonstration of McCune-Albright mutations in the liver of children with high gammaGT progressive cholestasis. J Hepatol 2000, 32:154-158.
73. El-Rifai N., Lumbroso S., Cartigny M., Weill J., Sultan C., Gottrand F. Infant cholestasis in McCune-Albright syndrome. Acta Paediatr 2004, 93:141.
74. Lumbroso S., Paris F., Sultan C. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome - a European Collaborative Study. J Clin Endocrinol Metab 2004, 89:2107-2113.
75. Shenker A., Weinstein L.S., Moran A., et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 1993, 123:509-518.
76. Bajpai A., Greenway A., Zacharin M. Platelet dysfunction and increased bleeding tendency in McCune-Albright syndrome. J Pediatr 2008, 153:287-289.
77. Belcastro V., Parnetti L., Prontera P., Donti E., Rossi A., Tambasco N. Hot water epilepsy and McCune-Albright syndrome: a case report. Seizure 2009, 18:161-162.
78. Cabanillas M., Aneiros A., Monteagudo B., Santos-Garcia D., Suarez-Amor O., Ramirez-Santos A. Epidermal nevus syndrome associated with polyostotic fibrous dysplasia, CNS lipoma, and aplasia cutis. Dermatol Online J 2009, 15:7.
79. Chen S.T., Fan P.C., Hwu W.L., Wu M.H. Fibrous dysplasia in a child with mitochondrial A8344G mutation. J Child Neurol 2008, 23:1447-1450.
80. Gasparetto E.L., de Carvalho Neto A., Bruck I., Antoniuk S. Tuberous sclerosis and fibrous dysplasia. Am J Neuroradiol 2003, 24:835-837.
81. Ghosal N., Furtado S.V., Santosh V., Sridhar M., Hegde A.S. Co-existing fibrous dysplasia and atypical lymphoplasmacyte-rich meningioma. Neuropathology 2007, 27:269-272.
82. Huston T.L., Simmons R.M. Ductal carcinoma in situ in a 27-year-old woman with McCune-Albright syndrome. Breast J 2004, 10:440-442.
83. Kate A., Gothi D., Joshi J.M. Marfan syndrome with multiseptate pneumothorax and mandibular fibrous dysplasia. Lung India 2009, 26:146-148.
84. Narayan R.L., Maldjian P.D. Restrictive lung disease and cor pulmonale secondary to polyostotic fibrous dysplasia. Int J Cardiol 2009, 131:e48-e50.
85. Ohata Y., Yamamoto T., Mori I., et al. Severe arterial hypertension: a possible complication of McCune-Albright syndrome. Eur J Pediatr 2009, 168:871-876.
86. Ozcan-Kara P., Mahmoudian B., Erbas B., Erbas T. McCune-Albright syndrome associated with acromegaly and bipolar affective disorder. Eur J Intern Med 2007, 18:600-602.
87. Roman R., Johnson M.C., Codner E., Boric M.A., aVila A., Cassorla F. Activating GNAS1 gene mutations in patients with premature thelarche. J Pediatr 2004, 145:218-222.
88. Tasar M., Ors F., Yetiser S., Ugurel M.S., Ucoz T. Multiple globoid meningiomas associated with craniomandibular fibrous dysplasia: case report. Clin Imaging 2004, 28:20-22.
89. Collins M.T., Chebli C., Jones J., et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001, 16:806-813.
90. Dent C.E., Gertner J.M. Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 1976, 45:411-420.
91. Zung A., Chalew S.A., Schwindinger W.F., et al. Urinary cyclic adenosine 3′,5′-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 1995, 80:3576-3581.
92. Yamamoto T., Miyamoto K., Ozono K., et al. Hypophosphatemic rickets accompanying McCune-Albright syndrome: evidence that a humoral factor causes hypophosphatemia. J Bone Miner Metab 2001, 19:287-295.
93. White K.E., Jonsson K.B., Karn G., et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 2001, 86:497-500.
94. Riminucci M., Collins M.T., Fedarko N.S., et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003, 112:683-692.
95. Kobayashi K., Imanishi Y., Koshiyama H., et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 2006, 78:2295-2301.
96. de Sanctis C., Lala R., Matarazzo P., et al. McCune-Albright syndrome: a longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab 1999, 12:817-826.
97. Hart E.S., Kelly M.H., Brillante B., et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 2007, 22:1468-1474.
98. Malchoff C.D., Reardon G., MacGillivray D.C., Yamase H., Rogol A.D., Malchoff D.M. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab 1994, 78:803-806.
99. Hall M.B., Sclar A.G., Gardner D.F. Albright s syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Oral Surg 1984, 57:616-619.
100. Kozasa T., Itoh H., Tsukamoto T., Kaziro Y. Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci USA 1988, 85:2081-2085.
101. Weinstein L.S. The stimulatory G protein alpha-subunit gene: mutations and imprinting lead to complex phenotypes. J Clin Endocrinol Metab 2001, 86:4662-4666.
102. Rao V.V., Schnittger S., Hansmann I. G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics 1991, 10:257-261.
103. Hayward B.E., Kamiya M., Strain L., et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998, 95:10038-10043.
104. Hayward B.E., Moran V., Strain L., Bonthron D.T. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998, 95:15475-15480.
105. Bastepe M. The GNAS Locus: quintessential complex gene encoding Gsalpha, XLalphas, and other imprinted transcripts. Curr Genomics 2007, 8:398-414.
106. Weinstein L.S., Yu S. The role of genomic imprinting of Galpha in the pathogenesis of Albright hereditary osteodystrophy. Trends Endocrinol Metab 1999, 10:81-85.
107. Swaroop A., Agarwal N., Gruen J.R., Bick D., Weissman S.M. Differential expression of novel Gs alpha signal transduction protein cDNA species. Nucleic Acids Res 1991, 19:4725-4729.
108. Kehlenbach R.H., Matthey J., Huttner W.B. XL alpha s is a new type of G protein. Nature 1994, 372:804-809.
109. Pasolli H.A., Huttner W.B. Expression of the extra-large G protein alpha-subunit XLalphas in neuroepithelial cells and young neurons during development of the rat nervous system. Neurosci Lett 2001, 301:119-122.
110. Pasolli H.A., Klemke M., Kehlenbach R.H., Wang Y., Huttner W.B. Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J Biol Chem 2000, 275:33622-33632.
111. Plagge A., Gordon E., Dean W., et al. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat Genet 2004, 36:818-826.
112. Plagge A., Kelsey G., Germain-Lee E.L. Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. J Endocrinol 2008, 196:193-214.
113. Bastepe M., Gunes Y., Perez-Villamil B., Hunzelman J., Weinstein L.S., Juppner H. Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit. Mol Endocrinol 2002, 16:1912-1919.
114. Klemke M., Pasolli H.A., Kehlenbach R.H., Offermanns S., Schultz G., Huttner W.B. Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J Biol Chem 2000, 275:33633-33640.
115. Linglart A., Mahon M.J., Kerachian M.A., et al. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3′,5′-monophosphate formation mediated by human XLalphas. Endocrinology 2006, 147:2253-2262.
116. Ischia R., Lovisetti-Scamihorn P., Hogue-Angeletti R., Wolkersdorfer M., Winkler H., Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin- like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997, 272:11657-11662.
117. Wroe S.F., Kelsey G., Skinner J.A., et al. An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci USA 2000, 97:3342-3346.
118. Freson K., Jaeken J., Van Helvoirt M., et al. Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum Mol Genet 2003, 12:1121-1130.
119. Klemke M., Kehlenbach R.H., Huttner W.B. Two overlapping reading frames in a single exon encode interacting proteins - a novel way of gene usage. Embo J 2001, 20:3849-3860.
120. Holmes R., Williamson C., Peters J., Denny P., Wells C. A comprehensive transcript map of the mouse Gnas imprinted complex. Genome Res 2003, 13:1410-1415.
121. Granneman J.G., Bannon M.J. Splicing pattern of Gs alpha mRNA in human and rat brain. J Neurochem 1991, 57:1019-1023.
122. Bray P., Carter A., Simons C., et al. Human cDNA clones for four species of G alpha s signal transduction protein. Proc Natl Acad Sci USA 1986, 83:8893-8897.
123. Robishaw J.D., Russell D.W., Harris B.A., Smigel M.D., Gilman A.G. Deduced primary structure of the alpha subunit of the GTP-binding stimulatory protein of adenylate cyclase. Proc Natl Acad Sci USA 1986, 83:1251-1255.
124. Novotny J., Svoboda P. The long (Gs(alpha)-L) and short (Gs(alpha)-S) variants of the stimulatory guanine nucleotide-binding protein. Do they behave in an identical way?. J Mol Endocrinol 1998, 20:163-173.
125. Frey U.H., Nuckel H., Dobrev D., et al. Quantification of G protein Gaalphas subunit splice variants in different human tissues and cells using pyrosequencing. Gene Expr 2005, 12:69-81.
126. Ihnatovych I., Hejnova L., Kostrnova A., Mares P., Svoboda P., Novotny J. Maturation of rat brain is accompanied by differential expression of the long and short splice variants of G(s)alpha protein: identification of cytosolic forms of G(s)alpha. J Neurochem 2001, 79:88-97.
127. van der Vuurst H., Hendriks M., Lapetina E.G., van Willigen G., Akkerman J.W. Maturation of megakaryoblastic cells is accompanied by upregulation of G(s)alpha-L subtype and increased cAMP accumulation. Thromb Haemost 1998, 79:1014-1020.
128. Novotny J., Svoboda P. The long (Gs(alpha)-L) and short (Gs(alpha)-S) variants of the stimulatory guanine nucleotide-binding protein. Do they behave in an identical way?. J Mol Endocrinol 1998, 20:163-173.
129. Kvapil P., Novotny J., Svoboda P., Ransnas L.A. The short and long forms of the alpha subunit of the stimulatory guanine-nucleotide-binding protein are unequally redistributed during (-)-isoproterenol-mediated desensitization of intact S49 lymphoma cells. Eur J Biochem 1994, 226:193-199.
130. Unson C.G., Wu C.R., Sakmar T.P., Merrifield R.B. Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of Galpha(s). J Biol Chem 2000, 275:21631-21638.
131. Wenzel-Seifert K., Kelley M.T., Buschauer A., Seifert R. Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha). J Pharmacol Exp Ther 2001, 299:1013-1020.
132. Reik W., Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001, 2:21-32.
133. Hayward B.E., Kamiya M., Strain L., et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998, 95:10038-10043.
134. Hayward B.E., Moran V., Strain L., Bonthron D.T. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998, 95:15475-15480.
135. Liu J., Chen M., Deng C., et al. Identification of the control region for tissue-specific imprinting of the stimulatory G protein alpha-subunit. Proc Natl Acad Sci USA 2005, 102:5513-5518.
136. Germain-Lee E.L., Ding C.L., Deng Z., et al. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002, 296:67-72.
137. Hayward B.E., Barlier A., Korbonits M., et al. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001, 107:R31-R36.
138. Mantovani G., Ballare E., Giammona E., Beck-Peccoz P., Spada A. The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002, 87:4736-4740.
139. Michienzi S., Cherman N., Holmbeck K., et al. GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha. Hum Mol Genet 2007, 16:1921-1930.
140. Mantovani G., Bondioni S., Locatelli M., et al. Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J Clin Endocrinol Metab 2004, 89:6316-6319.
141. Constancia M., Pickard B., Kelsey G., Reik W. Imprinting mechanisms. Genome Res 1998, 8:881-900.
142. Yan H., Zhou W. Allelic variations in gene expression. Curr Opin Oncol 2004, 16:39-43.
143. Vallar L., Spada A., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH secreting pituitary adenomas. Nature 1987, 330:566-568.
144. Landis C.A., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989, 340:692-696.
145. Lyons J., Landis C.A., Harsh G., et al. Two G protein oncogenes in human endocrine tumors. Science 1990, 249:655-659.
146. Suarez H.G., du Villard J.A., Caillou B., Schlumberger M., Parmentier C., Monier R. gsp mutations in human thyroid tumours. Oncogene 1991, 6:677-679.
147. Spada A., Lania A., Ballare E. G protein abnormalities in pituitary adenomas. Mol Cell Endocrinol 1998, 142:1-14.
148. Ivan M. An amphotropic retroviral vector expressing a mutant gsp oncogene: effects on human thyroid cells in vitro. J Clin Endocrinol Metab 1997, 82:2702-2709.
149. Chen J., Iyengar R. Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s. Science 1994, 263:1278-1281.
150. Shenker A., Weinstein L.S., Sweet D.E., Spiegel A.M. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994, 79:750-755.
151. Alman B.A., Greel D.A., Wolfe H.J. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 1996, 14:311-315.
152. Bianco P., Riminucci M., Majolagbe A., et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000, 15:120-128.
153. Candeliere G.A., Roughley P.J., Glorieux F.H. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 1997, 21:201-206.
154. Riminucci M., Fisher L.W., Majolagbe A., et al. A novel GNAS1 mutation, R201G, in McCune-Albright syndrome. J Bone Miner Res 1999, 14:1987-1989.
155. Gorelov V.N., Dumon K., Barteneva N.S., Palm D., Roher H.D., Goretzki P.E. Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene. J Cancer Res Clin Oncol 1995, 121:219-224.
156. Cooper D.N., Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 1990, 85:55-74.
157. Bourne H.R. How receptors talk to trimeric G proteins. Curr Opin Cell Biol 1997, 9:134-142.
158. Spiegel A.M. Inborn errors of signal transduction: mutations in G proteins and G protein-coupled receptors as a cause of disease. J Inherit Metab Dis 1997, 20:113-121.
159. Spiegel A.M. The molecular basis of disorders caused by defects in G proteins. Horm Res 1997, 47:89-96.
160. Bourne H.R., Landis C.A., Masters S.B. Hydrolysis of GTP by the alpha-chain of Gs and other GTP binding proteins. Proteins 1989, 6:222-230.
161. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci USA 1977, 74:3307-3311.
162. Idowu B.D., Al-Adnani M., O Donnell P., et al. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology 2007, 50:691-704.
163. Wedegaertner P.B., Bourne H.R., von Zastrow M. Activation-induced subcellular redistribution of Gs alpha. Mol Biol Cell 1996, 7:1225-1233.
164. Iyengar R. Gating by cyclic AMP: expanded role for an old signaling pathway. Science 1996, 271:461-463.
165. Lania A., Persani L., Ballare E., Mantovani S., Losa M., Spada A. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab 1998, 1624-1628.
166. Nemoz G., Sette C., Hess M., Muca C., Conti M. Activation of cyclic nucleotide phosphodiesterases in FRTL-5 thyroid cells expressing a constitutively active Gs alpha. Mol Endocrinol 1995, 9:1279-1287.
167. Zachary I., Masters S.B., Bourne H.R. Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gs alpha. Biochem Biophys Res Commun 1990, 168:1184-1193.
168. Piersanti S., Remoli C., Saggio I., et al. Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res 2010, 25:1103-1116.
169. Ballare E., Mantovani S., Lania A., Di Blasio A.M., Vallar L., Spada A. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 1998, 83:4386-4390.
170. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986, 29:321-324.
171. Riminucci M., Saggio I., Robey P.G., Bianco P. Fibrous dysplasia as a stem cell disease. J Bone Miner Res 2006, 21(Suppl 2):P125-P131.
172. Bartolomei M.S., Tilghman S.M. Genomic imprinting in mammals. Annu Rev Genet 1997, 31:493-525.
173. Liu J., Yu S., Litman D., Chen W., Weinstein L.S. Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 2000, 20:5808-5817.
174. Weinstein L.S., Chen M., Xie T., Liu J. Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol Sci 2006, 27:260-266.
175. Weinstein L.S., Liu J., Sakamoto A., Xie T., Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology 2004, 145:5459-5464.
176. Yu S., Gavrilova O., Chen H., et al. Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest 2000, 105:615-623.
177. Yu S., Yu D., Lee E., et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci USA 1998, 95:8715-8720.
178. Zheng H., Radeva G., McCann J.A., Hendry G.N., Goodyer C.G. G alpha s transcripts are biallelically expressed in human kidney cortex: implications for pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2001, 86:4627-4629.
179. Mantovani G., Bondioni S., Lania A.G., et al. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J Clin Endocrinol Metab 2004, 89:3007-3009.
180. Campbell R., Gosden C.M., Bonthron D.T. Parental origin of transcription from the human GNAS1 gene. J Med Genet 1994, 31:607-614.
181. Weinstein L.S., Yu S., Ecelbarger C.A. Variable imprinting of the heterotrimeric G protein G(s) alpha-subunit within different segments of the nephron. Am J Physiol Renal Physiol 2000, 278:F507-F514.
182. Harris W.H., Dudley H.R., Barry R.J. The natural history of fibrous dysplasia. J Bone Joint Surg 1962, 44A:207-233.
183. Riminucci M., Liu B., Corsi A., et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 1999, 187:249-258.
184. Miller S.S., Wolf A.M., Arnaud C.D. Bone cells in culture: morphologic transformation by hormones. Science 1976, 192:1340-1343.
185. Corsi A., Collins M.T., Riminucci M., et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Miner Res 2003, 18:1235-1246.
186. Bianco P. Structure and mineralization of bone. Mineralization in Biological Systems 1992, 243-268. CRC Press, Boca Raton. E. Bonucci (Ed.).
187. Gehron Robey P., Bianco P. The cellular biology and molecular biochemistry of bone formation. Disorders of Bone and Mineral Metabolism 2002, 199-226. Raven Press, New York. 2nd edn. Coe, Favus (Eds.).
188. Boyde A., Maconnachie E., Reid S.A., Delling G., Mundy G.R. Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan. Electron Microsc 1986, (Pt 4):1537-1554.
189. Boyde A., Travers R., Glorieux F.H., Jones S.J. The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 1999, 64:185-190.
190. Yamamoto T. Clinical approach to clarifying the mechanism of abnormal bone metabolism in McCune-Albright syndrome. J Bone Miner Metab 2006, 24:7-10.
191. Delling G. Bone morphology in primary hyperparathyroidism - a qualitative and quantitative study of 391 cases. Appl Pathol 1987, 5:147-159.
192. Arden R.L., Bahu S.J., Lucas D.R. Mandibular aneurysmal bone cyst associated with fibrous dysplasia. Otolaryngol Head Neck Surg 1997, 117:S153-S156.
193. Bandiera S., Bacchini P., Bertoni F. Secondary aneurysmal bone cyst simulating malignant transformation in fibrous dysplasia. Orthopedics 2000, 23:1205-1207.
194. Burd T.A., Lowry K.J., Stokesbary S.J., Allen I.C. Aneurysmal bone cyst associated with fibrous dysplasia. Orthopedics 2001, 24:1087-1089.
195. Suzuki F., Fukuda S., Yagi K., Chida E., Inuyama Y. A rare aneurysmal bone cyst of the maxillary sinus: a case report. Auris Nasus Larynx 2001, 28(Suppl):S131-S137.
196. Dowler J.G., Sanders M.D., Brown P.M. Bilateral sudden visual loss due to sphenoid mucocele in Albright s syndrome. Br J Ophthalmol 1995, 79:503-504.
197. Hirabayashi S., Kagawa K., Ohkubo E., Sugawara Y., Sakurai A. Craniofacial fibrous dysplasia with rapidly increasing proptosis due to a mucocele behind the globe. Ann Plast Surg 1998, 40:182-185.
198. Fischer J.A., Bollinger A., Lichtlen P., Wellauer J. Fibrous dysplasia of the bone and high cardiac output. Am J Med 1970, 49:140-146.
199. Riminucci M., Corsi A., Kuznetsov S., Licci S., Gehron Robey P., Bianco P. Angiogenesis and expression of alpha-sm actin in fibrous dysplasia of bone. Bone 2001, 28(s):S124.
200. Schmitt-Graff A., Skalli O., Gabbiani G. Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch B Cell Pathol Incl Mol Pathol 1989, 57:291-302.
201. Bianco P., Bonucci E. Endosteal surfaces in hyperparathyroidism: an enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies. Virchows Arch A Pathol Anat Histopathol 1991, 419:425-431.
202. Schipani E., Lanske B., Hunzelman J., et al. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 1997, 94:13689-13694.
203. Hermann G., Klein M., Abdelwahab I.F., Kenan S. Fibrocartilaginous dysplasia. Skeletal Radiol 1996, 25:509-511.
204. Choi I.H., Kim C.J., Cho T.J., et al. Focal fibrocartilaginous dysplasia of long bones: report of eight additional cases and literature review. J Pediatr Orthop 2000, 20:421-427.
205. Park Y.K., Unni K.K., McLeod R.A., Pritchard D.J. Osteofibrous dysplasia: clinicopathologic study of 80 cases. Hum Pathol 1993, 24:1339-1347.
206. Sakamoto A., Oda Y., Iwamoto Y., Tsuneyoshi M. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin- embedded tissues. J Mol Diagn 2000, 2:67-72.
207. Voytek T.M., Ro J.Y., Edeiken J., Ayala A.G. Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum. Am J Surg Pathol 1995, 19:775-781.
208. Campanacci M., Laus M., Boriani S. Multiple non-ossifying fibromata with extraskeletal anomalies: a new syndrome?. J Bone Joint Surg 1983, 65B:627-632.
209. Ruggieri P., Sim F.H., Bond J.R., Unni K.K. Malignancies in fibrous dysplasia. Cancer 1994, 73:1411-1424.
210. Hoshi M., Matsumoto S., Manabe J., et al. Malignant change secondary to fibrous dysplasia. Int J Clin Oncol 2006, 11:229-235.
211. Hansen M.R., Moffat J.C. Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: Case report. Skull Base 2003, 13:79-83.
212. Jhala D.N., Eltoum I., Carroll A.J., et al. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud s syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol 2003, 34:1354-1357.
213. Nguyen B.D., Ram P.C. Mazabraud s syndrome with sarcomatous transformation: scintigraphic and radiologic imaging. Clin Nucl Med 2005, 30:829-830.
214. Crawford E.A., Brooks J.S., Ogilvie C.M. Osteosarcoma of the proximal part of the radius in Mazabraud syndrome. A case report. J Bone Joint Surg Am 2009, 91:955-960.
215. Dal Cin P., Bertoni F., Bacchini P., Hagemeijer A., Van den Berghe H. Fibrous dysplasia and the short arm of chromosome 12. Histopathology 1999, 34:279-280.
216. Dal Cin P., Sciot R., Brys P., et al. Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. CHromosomes And MorPhology. Cancer Genet Cytogenet 2000, 122:30-32.
217. Dal Cin P., Sciot R., Speleman F., et al. Chromosome aberrations in fibrous dysplasia. Cancer Genet Cytogenet 1994, 77:114-117.
218. Mertens F., Albert A., Heim S., et al. Clonal structural chromosome aberrations in fibrous dysplasia. Genes Chromosomes Cancer 1994, 11:271-272.
219. Gong L., Zhang W., Su Q. Clonal status of fibrous dysplasia. Pathology 2008, 40:392-395.
220. Mikami M., Koizumi H., Ishii M., Nakajima H. The identification of monoclonality in fibrous dysplasia by methylation-specific polymerase chain reaction for the human androgen receptor gene. Virchows Arch 2004, 444:56-60.
221. Kim G.T., Lee J.K., Choi B.J., Kim J., Han S.H., Kwon Y.D. Malignant transformation of monostotic fibrous dysplasia in the mandible. J Craniofac Surg 2010, 21:601-603.
222. Beuerlein M.E., Schuller D.E., DeYoung B.R. Maxillary malignant mesenchymoma and massive fibrous dysplasia. Arch Otolaryngol Head Neck Surg 1997, 123:106-109.
223. Bohay R.N., Daley T. Osteosarcoma and fibrous dysplasia: radiographic features in the differential diagnosis: a case report. J Can Dent Assoc 1993, 59:931-934.
224. Harris N.L., Eilert R.E., Davino N., Ruyle S., Edwardson M., Wilson V. Osteogenic sarcoma arising from bony regenerate following Ilizarov femoral lengthening through fibrous dysplasia. J Pediatr Orthop 1994, 14:123-129.
225. Lopez-Ben R., Pitt M.J., Jaffe K.A., Siegal G.P. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud s syndrome. Skeletal Radiol 1999, 28:522-526.
226. Ruggieri P., Sim F.H., Bond J.R., Unni K.K. Osteosarcoma in a patient with polyostotic fibrous dysplasia and Albright s syndrome. Orthopedics 1995, 18:71-75.
227. Blanco P., Schaeverbeke T., Baillet L., Lequen L., Bannwarth B., Dehais J. Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case 1999, 66:177-179. R.E. Rev (Ed.).
228. Heller A.J., DiNardo L.J., Massey D. Fibrous dysplasia, chondrosarcoma, and McCune-Albright syndrome. Am J Otolaryngol 2001, 22:297-301.
229. Cheng M.H., Chen Y.R. Malignant fibrous histiocytoma degeneration in a patient with facial fibrous dysplasia. Ann Plast Surg 1997, 39:638-642.
230. Ohmori K., Matsui H., Kanamori M., Yudoh K., Yasuda T., Terahata S. Malignant fibrous histiocytoma secondary to fibrous dysplasia. A case report. Int Orthop 1996, 20:385-388.
231. Doganavsargil B., Argin M., Kececi B., Sezak M., Sanli U.A., Oztop F. Secondary osteosarcoma arising in fibrous dysplasia, case report. Arch Orthop Trauma Surg 2009, 129:439-444.
232. Fu C.J., Hsu C.Y., Shih T.T., Wu M.Z. Monostotic fibrous dysplasia of the thoracic spine with malignant transformation. J Formos Med Assoc 2004, 103:711-714.
233. Reis C., Genden E.M., Bederson J.B., Som P.M. A rare spontaneous osteosarcoma of the calvarium in a patient with long-standing fibrous dysplasia: CT and MR findings. Br J Radiol 2008, 81:e31-e34.
234. Fukuroku J., Kusuzaki K., Murata H., et al. Two cases of secondary angiosarcoma arising from fibrous dysplasia. Anticancer Res 1999, 19:4451-4457.
235. Kanazawa I., Yamauchi M., Yano S., et al. Osteosarcoma in a pregnant patient with McCune-Albright syndrome. Bone 2009, 45:603-608.
236. Steiner G.C., Forest M., Vacher-Lavenu M.C. Ultrastructure of low-grade intraosseous osteosarcoma of bone: a comparative study with fibrous dysplasia and parosteal osteosarcoma. Ultrastruct Pathol 2006, 30:293-299.
237. Pollandt K., Engels C., Kaiser E., Werner M., Delling G. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma. Virchows Arch 2001, 439:170-175.
238. Owen M. Uptake of [3H]uridine into precursor pools and RNA in osteogenic cells. J Cell Sci 1967, 2:39-49.
239. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
240. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
241. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
242. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
243. Bianco P., Riminucci M., Kuznetsov S., Robey P.G. Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 1999, 9:159-173.
244. Bianco P., Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000, 105:1663-1668.
245. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments]. Cell 1997, 89:747-754.
246. Riminucci M., Yamada S., Festuccia C., et al. Collagenolytic properties of GNAS1 mutated osteogenic cells from fibrous dysplasia and their in vivo correlate. J Bone Min Res 2000, 15(s):S212. (Abstr.).
247. Bianco P., Gehron Robey P. Diseases of bone and the stromal cell lineage. J Bone Min Res 1999, 14.
248. Bianco P., Costantini M., Dearden L.C., Bonucci E. Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 1988, 68:401-403.
249. Watkins D.C., Rapiejko P.J., Ros M., Wang H., Malbon C.C. G protein mRNA levels during adipocyte differentiation. Biochem Biophys Res Commun 1989, 165:929-933.
250. Wang H., Watkins D.C., Malbon C.C. Antisense oligodeoxynucleotides to Gs protein alpha subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature 1992, 358:334-337.
251. Candeliere G.A., Glorieux F.H., Prud Homme J., St.-Arnaud R. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995, 332:1546-1551.
252. Ruther U., Garber C., Komitowski D., Muller R., Wagner E.F. Deregulated c-fos expression interferes with normal bone development in trasngenic mice. Nature 1987, 325:412-416.
253. Motomura T., Kasayama S., Takagi M., et al. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J Bone Miner Res 1998, 13:1084-1091.
254. Stanton R.P., Hobson G.M., Montgomery B.E., Moses P.A., Smith-Kirwin S.M., Funanage V.L. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia. J Bone Miner Res 1999, 14:1104-1110.
255. Riminucci M., Kuznetsov S.A., Cherman N., Corsi A., Bianco P., Gehron Robey P. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 2003, 33:434-442.
256. Fraser W.D., Walsh C.A., M.A.B, et al. Parathyroid hormone-related protein in the aetiology of fibrous dysplasia of bone in the McCune Albright syndrome. Clin Endocrinol (Oxf) 2000, 53:621-628.
257. Warshafsky B., Aubin J.E., Heersche J.N. Cytoskeleton rearrangements during calcitonin-induced changes in osteoclast motility in vitro. Bone 1985, 6:179-185.
258. Werb Z., Hembry R.M., Murphy G., Aggeler J. Commitment to expression of the metalloendopeptidase collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 1986, 102:697-702.
259. Teti A., Farina A.R., Villanova I., et al. Activation of MMP-2 by human GCT23 giant cell tumor cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape dependent. Int J Cancer 1998, 77:82-93.
260. Overall C.M., Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J Biol Chem 1990, 265:21141-21151.
261. Kitoh H., Yamada Y., Nogami H. Different genotype of periosteal and endosteal cells of a patient with polyostotic fibrous dysplasia. J Med Genet 1999, 36:724-725.
262. Kuznetsov S.A., Cherman N., Riminucci M., Collins M.T., Robey P.G., Bianco P. Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res 2008, 23:1731-1740.
263. Sissons H.A., Malcolm A.J. Fibrous dysplasia of bone: case report with autopsy study 80 years after the original clinical recognition of the bone lesions. Skeletal Radiol 1997, 26:177-183.
264. Alvares L.C., Capelozza A.L., Cardoso C.L., Lima M.C., Fleury R.N., Damante J.H. Monostotic fibrous dysplasia: a 23-year follow-up of a patient with spontaneous bone remodeling. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:229-234.
265. Chanson P., Salenave S., Orcel P. McCune-Albright syndrome in adulthood. Pediatr Endocrinol Rev 2007, 4(Suppl 4):453-462.
266. Feuillan P.P., Foster C.M., Pescovitz O.H., et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986, 315:1115-1119.
267. Feuillan P.P., Jones J., Cutler G.B. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993, 77:647-651.
268. Chapurlat R., Meunier P.J. Fibrous dysplasia of bone. Baillière s Clin Rheum 2000, 14:385-398.
269. Imanaka M., Iida K., Nishizawa H., et al. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method. Intern Med 2007, 46:1577-1583.
270. Kalfa N., Philibert P., Audran F., et al. Searching for somatic mutations in McCune-Albright syndrome: a comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples. Eur J Endocrinol 2006, 155:839-843.
271. Karadag A., Riminucci M., Bianco P., et al. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome. Nucleic Acids Res 2004, 32:e63.
272. Lietman S.A., Ding C., Levine M.A. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Joint Surg Am 2005, 87:2489-2494.
273. Guille J.T., Kumar S.J., MacEwen G.D. Fibrous dysplasia of the proximal part of the femur. J Bone Joint Surg 1998, 80A:648-658.
274. Leet A.I., Chebli C., Kushner H., et al. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res 2004, 19:571-577.
275. Leet A.I., Wientroub S., Kushner H., et al. The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children. J Bone Joint Surg Am 2006, 88:818-823.
276. Ippolito E., Bray E.W., Corsi A., et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 2003, 12:155-177.
277. Andrisano A., Soncini G., Calderoni P.P., Stilli S. Critical review of infantile fibrous dysplasia: surgical treatment. J Ped Orthop 1991, 11:478-481.
278. Stephenson R.B., London M.D., Hankin F.M., Kaufer H. Fibrous dysplasia. J Bone Joint Surg 1987, 69A:400-409.
279. Keijser L.C., Van Tienen T.G., Schreuder H.W., Lemmens J.A., Pruszczynski M., Veth R.P. Fibrous dysplasia of bone: management and outcome of 20 cases. J Surg Oncol 2001, 76:157-166. discussion 167-8.
280. Freeman B.H., Bray E.W., Meyer L.C. Multiple osteotomies with Zyckel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur. J Bone Joint Surg 1987, 69A:691-698.
281. Leet A.I., Magur E., Lee J.S., Wientroub S., Robey P.G., Collins M.T. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am 2004, 86A:531-537.
282. Mancini F., Corsi A., De Maio F., Riminucci M., Ippolito E. Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J 2009, 18:196-202.
283. Schoenfeld A.J., Koplin S.A., Garcia R., et al. Monostotic fibrous dysplasia of the spine: a report of seven cases. J Bone Joint Surg Am 2010, 92:984-988.
284. Lee J.S., FitzGibbon E., Butman J.A., et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 2002, 347:1670-1676.
285. Cutler C.M., Lee J.S., Butman J.A., et al. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery 2006, 59:1011-1017. discussion 1017-8.
286. Riminucci M., Collins M.T., Jane J., Lin K.Y. Craniofacial fibrous dysplasia. Textbook of Craniofacial Surgery 2001, 366-381. WB Saunders, Orlando-Philadelphia. J. Jane, K.Y. Lin (Eds.).
287. Chapurlat R.D., Delmas P.D., Liens D., Meunier P.J. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997, 12:1746-1752.
288. Devogelaer J.P. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol 2000, 12:331-335.
289. Lala R., Matarazzo P., Bertelloni S., Buzi F., Rigon F., de Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000, 89:188-193.
290. Lane J.M., Khan S.N., O Connor W.J., et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 2001, 6-12.
291. Weinstein R.S. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res 1997, 12:1314-1315.
292. Pfeilschifter J., Ziegler R. [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome]. Med Klin 1998, 93:352-359.
293. Liens D., Delmas P.D., Meunier P.J. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994, 343:953-954.
294. Chapurlat R.D., Hugueny P., Delmas P.D., Meunier P.J. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone 2004, 35:235-242.
295. Kos M., Luczak K., Godzinski J., Klempous J. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg 2004, 32:10-15.
296. Lala R., Matarazzo P., Andreo M., et al. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006, 19(Suppl 2):583-593.
297. Plotkin H., Rauch F., Zeitlin L., Munns C., Travers R., Glorieux F.H. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 2003, 88:4569-4575.
298. Chan B., Zacharin M. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. J Pediatr Endocrinol Metab 2006, 19:75-80.
299. Chapurlat R.D. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 2006, 21(Suppl 2):P114-P119.
300. Chao K., Katznelson L. Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull. J Neurosurg 2008, 109:889-892.
301. Mansoori L.S., Catel C.P., Rothman M.S. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review. Endocr Pract 2010, 21:1-14.
302. Makitie A.A., Tornwall J., Makitie O. Bisphosphonate treatment in craniofacial fibrous dysplasia - a case report and review of the literature. Clin Rheumatol 2008, 27:809-812.
303. Glorieux F.H. Bisphosphonate therapy for severe osteogenesis imperfecta. J Pediatr Endocrinol Metab 2000, 13(Suppl 2):989-992.
304. Glorieux F.H., Bishop N.J., Plotkin H., Chabot G., Lanoue G., Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998, 339:947-952.
305. Plotkin H., Rauch F., Bishop N.J., et al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000, 85:1846-1850.
306. Luckman S.P., Hughes D.E., Coxon F.P., Graham R., Russell G. Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998, 13:581-589.
307. Wedegaertner P.B., Chu D.H., Wilson P.T., Levis M.J., Bourne H.R. Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. J Biol Chem 1993, 268:25001-25008.
308. Iniguez-Lluhi J.A., Simon M.I., Robishaw J.D., Gilman A.G. G protein beta gamma subunits synthesized in Sf9 cells. Functional characterization and the significance of prenylation of gamma. J Biol Chem 1992, 267:23409-23417.
309. Muntz K.H., Sternweis P.C., Gilman A.G., Mumby S.M. Influence of gamma subunit prenylation on association of guanine nucleotide-binding regulatory proteins with membranes. Mol Biol Cell 1992, 3:49-61.
310. Fukada Y. Prenylation and carboxylmethylation of G-protein gamma subunit. Methods Enzymol 1995, 250:91-105.
311. Wedegaertner P.B., Bourne H.R. Activation and depalmitoylation of Gs alpha. Cell 1994, 77:1063-1070.
312. Iiri T., Backlund P.S., Jones T.L., Wedegaertner P.B., Bourne H.R. Reciprocal regulation of Gs alpha by palmitate and the beta gamma subunit. Proc Natl Acad Sci USA 1996, 93:14592-14597.
313. Bianco P., Robey P.G. An animal model of fibrous dysplasia. Mol Med Today 1999, 5:322-323.
314. Bianco P., Gehron Robey P. Stem cells in tissue engineering. Nature 2001.
315. Di George A.M. Albright syndrome: is it coming of age?. J Pediatr 1975, 87:1018-1020.